• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION FINELINE II STEROX; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION FINELINE II STEROX; IMPLANTABLE LEAD Back to Search Results
Model Number 4457
Medical Device Problem Codes Signal Artifact/Noise (1036); Failure to Capture (1081); High impedance (1291)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/01/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
If pertinent information is provided in the future, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that this pacemaker system triggered a lead safety switch (lss) on the right ventricular (rv) lead due to an abrupt high out of range pacing impedance measurement in the bipolar configuration, measuring greater than 3000 ohms.The health care professional (hcp) was unable to recreate the out of range measurement in bipolar; however, it was noted that unipolar pacing impedance measured at about 2200 ohms.Minimal noise was observed in bipolar, and loss of capture (loc) was exhibited in unipolar and bipolar.The hcp implemented programming changes that technical services (ts) recommended.Prior to the lss, it was noted that the patient experienced a fall.Subsequently, ts suspected there was a lead fracture and recommended performing a chest x-ray.No adverse patient effects were reported.This rv lead remains in service.
 
Event or Problem Description
It was reported that this pacemaker system triggered a lead safety switch (lss) on the right ventricular (rv) lead due to an abrupt high out of range pacing impedance measurement in the bipolar configuration, measuring greater than 3000 ohms.The health care professional (hcp) was unable to recreate the out of range measurement in bipolar; however, it was noted that unipolar pacing impedance measured at about 2200 ohms.Minimal noise was observed in bipolar, and loss of capture (loc) was exhibited in unipolar and bipolar.The hcp implemented programming changes that technical services (ts) recommended.Prior to the lss, it was noted that the patient experienced a fall.Subsequently, ts suspected there was a lead fracture and recommended performing a chest x-ray.No adverse patient effects were reported.This rv lead remains in service.
 
Additional Manufacturer Narrative
This lead was not returned for analysis, as it remains implanted and in service; therefore, a technical analysis could not be performed.A review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.A risk review was completed and confirmed that the event of pacing impedance high out of range was defined in the risk documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Review of labeling determined that the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance to labeling.The manual was unlikely to be the cause of the reported complaint; translation, wording, or graphics does not require further review.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk of device.If pertinent information is provided in the future, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FINELINE II STEROX
Common Device Name
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key24652016
Report Number2124215-2026-15597
Device Sequence Number10008547
Product Code DTB
UDI-Device Identifier00802526060915
UDI-Public(01)00802526060915(17)080831
Combination Product (Y/N)Y
Initial Reporter StateWV
Initial Reporter CountryUS
PMA/510(K) Number
P960004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2006
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/01/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date08/31/2008
Device Model Number4457
Device Catalogue Number4457
Device Lot Number520279
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/02/2026
Supplement Date Received by Manufacturer05/29/2026
Initial Report FDA Received Date03/20/2026
Supplement Report FDA Received Date06/01/2026
Date Device Manufactured08/31/2006
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age73 YR
Patient SexMale
-
-